Briggs Morrison - Feb 2, 2022 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Signature
/s/ Michael A. Metzger, Attorney-in-fact
Stock symbol
SNDX
Transactions as of
Feb 2, 2022
Transactions value $
$2,526,400
Form type
4
Date filed
2/3/2022, 04:32 PM
Previous filing
Jan 19, 2022
Next filing
Apr 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNDX Stock Options (Right to buy) Award $2.53M +160K $15.79 160K Feb 2, 2022 Common Stock 160K $15.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded on 02/02/2022 were in the form of stock options issued pursuant to the Syndax Pharmaceuticals, Inc. 2015 Omnibus Incentive Plan. Options to purchase 100,000 shares of common stock shall vest in 48 successive equal monthly installments measured from 02/02/2022. Options to purchase 60,000 shares of common stock shall vest periodically upon the Issuer achieving certain milestones.